BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
<BROVANA, advise, monoamine oxidase inhibitors>, <BROVANA, advise, tricyclic antidepressants>, <beta2-agonists, advise, monoamine oxidase inhibitors>, <beta2-agonists, advise, tricyclic antidepressants>, <monoamine oxidase inhibitors, effect, adrenergic agonists>, <tricyclic antidepressants, effect, adrenergic agonists>